Skip to main content
TISSUE REGENIX GROUP PLC logo

TISSUE REGENIX GROUP PLC — Investor Relations & Filings

Ticker · TRX ISIN · GB00BNTXR104 LEI · 213800PNOD5UHQUFJI36 IL Manufacturing
Open in API
Filings indexed 405 across all filing types
Latest filing 2021-06-23 Director's Dealing
Country GB United Kingdom
Listing IL TRX

About TISSUE REGENIX GROUP PLC

https://www.tissueregenix.com/

Tissue Regenix Group PLC is a medical technology company specializing in regenerative medicine. The company develops and commercializes biological products designed to repair and regenerate human tissue. It employs proprietary decellularization platform technologies to process human and animal tissues, creating acellular scaffolds. When implanted, these scaffolds support the patient's own cells in repopulating and regenerating the damaged area. The company's portfolio serves three main clinical areas: biosurgery for complex wound care, orthopaedics for sports medicine and bone graft substitutes, and dental applications for tissue and bone repair. Key products include DermaPure®, OrthoPure® XT, and the Matrix® line of bone graft substitutes.

Recent filings

Filing Released Lang Actions
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is identified by the 'RNS Number' header and explicitly mentions 'RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' The core content details a 'Director/PDMR Shareholding' transaction where a Non-executive director purchased shares. This type of insider transaction report, when filed via the RNS system, falls under the category of Director's Dealing (DIRS). Although it is an RNS announcement, the specific content maps directly to DIRS, which is a more specific classification than the general RNS fallback.
2021-06-23 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and is distributed via 'RNS Number'. This form is used to report changes in significant share ownership (crossing thresholds). The content details the resulting situation of voting rights held by 'The Diverse Income Trust plc'. This directly corresponds to the definition of a Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2021-06-10 English
Result of AGM
AGM Information Classification · 1% confidence The document explicitly states it is the 'Result of AGM' and provides a detailed table showing the results of the poll for various resolutions voted upon during the Annual General Meeting (AGM). This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it relates to the AGM, the core content is the voting outcome, not the presentation materials (AGM-R) or proxy solicitation (PSI). The RNS header confirms it is a regulatory announcement, but DVA is the most specific category.
2021-06-03 English
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is an official announcement filed via RNS (Regulatory News Service), indicated by the 'RNS Number' header and the closing statement referencing the London Stock Exchange and FCA. The content explicitly details a transaction where a Director/PDMR (Chief Executive Officer, Daniel Lee) acquired shares of the company. This perfectly matches the definition of a Director's Dealing report. The specific filing code for this type of insider transaction disclosure is DIRS.
2021-05-11 English
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is an official announcement disseminated via RNS (Regulatory News Service) of the London Stock Exchange, indicated by the 'RNS Number' and the concluding boilerplate text referencing RNS and the FCA. The content explicitly details a 'Director/PDMR Shareholding' transaction, specifically the acquisition of Ordinary Shares by the Chief Financial Officer (David Cocke). This type of insider transaction reporting, especially when filed through a primary regulatory channel like RNS, falls under the category of Director's Dealing (DIRS). Although it is an RNS filing, DIRS is a more specific and accurate classification than the general RNS fallback.
2021-05-10 English
Grant of share options
Share Issue/Capital Change Classification · 1% confidence The document is identified by the 'RNS Number' header and contains a date (05 May 2021) and details about the grant of share options (RSUs) to senior management (CEO and CFO). This type of filing, which reports personal share transactions by company directors and executives (insider trades), specifically matches the definition for Director's Dealing (DIRS). Although it is an RNS announcement, the content is highly specific to insider transactions, making DIRS a more precise classification than the general RNS fallback.
2021-05-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.